EpilepsyEMO-INTRANCT07544563
Phenotypic Exploration During Sensory Stimulation in an Acoustic Chamber
An observational study of Epilepsy and Anxiety, run by Centre Hospitalier St Anne at 1 site in France.
Trial summary
An observational behavioural and neurophysiological study of the effects of controlled sensory stimulation (such as music, for example) on brain function Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Epilepsy, Anxiety, Depression Anxiety Disorder
- How many people
- 320 participants
- Where
- 1 siteFrance
- Study dates
- 2 Dec 2025to 2 Dec 2035
- Phase
- Observational
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: GHU paris Sainte Anne
Who may be able to join
- For patients : epilepsy
- For healthy volunteers: age > 18 yo
Who cannot join
- For patients and healthy volonteers : Deafness
- For healthy volunteers : History of neurological conditions (including stroke, coma, epilepsy, neuro-inflammatory or neurodegenerative disease) or diagnosed cognitive impairment
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
France1 site, 1 recruiting
- Recruiting
GHU Paris Sainte Anne
Paris, 75014
Estelle Pruvost-Robieux, MD, PHD, +33145658189, e.pruvost@ghu-paris.fr
Estelle Pruvost-Robieux, MD, PHD
About this study
Official title: Exploration phénotypique en Contexte de Stimulations Sensorielles en Chambre Acoustique
An observational behavioural and neurophysiological study of the effects of controlled sensory stimulation (such as music, for example) on brain function
- Conditions
- Epilepsy, Anxiety, Depression Anxiety Disorder
- Medical subject headings
- Epilepsy, Anxiety Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Epilepsy and music | Epileptic patients (with or without mood disorders) exposed to music stimulations |
What is being measured
The primary outcome is the main question the study is designed to answer.
Neuronal networks
Description of the neural networks involved during exposure to sensory stimuli
Measured: All along the study (8 years)
Secondary outcomes (3)
Psychologic outcome : anxiety
Assessment of the Generalized Anxiety Disorder-7 (GAD7) in the exposed patients across the hospitalization :
minimum value 0; maximum 21; higher scores mean a worse outcome
Measured: 8 years
Psychologic outcome 2 : depression
Assessment of the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E) in the exposed patients across the hospitalization : minimum value 6; maximum 24; higher scores mean a worse outcome
Measured: 8 years
Quality of life measure
Assessment of the QOLIE-31(quality of life in epilepsy) scale among exposed patients
Measured: 8 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Apr 2026
- Study start2 Dec 2025
- Primary completion2 Dec 2035 (estimated)
- Study completion2 Dec 2035 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for EpilepsyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 320 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier St Anne
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07544563
- Sponsor's protocol ID
- D25-P008
- Acronym
- EMO-INTRA
- Status last verified
- Apr 2026
- First submitted
- 3 Apr 2026
- Last updated
- 22 Apr 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No